Abstract:Objective: To compare outcomes of single-lung retransplantation (SLRTx) and double-lung retransplantation (DLRTx) after an initial double-lung transplantation. Methods: The Organ Procurement and Transplantation Network/United Network for Organ Sharing database between May 2005 and December 2022 was retrospectively analyzed. Multiorgan transplantations, repeated retransplantations, and lung retransplantations when the status of the initial transplantation was unknown were excluded. Results: A total of 891 patients were included in the analysis, included 698 (78.3%) with DLRTx and 193 (21.7%) with SLRTx. The mean lung allocation score was higher in the DLRTx group (59.6 ± 20.7 vs 55.1 ± 19.3; P = .007). The use of extracorporeal membrane oxygenation (ECMO) bridge to lung transplantation was similar in the 2 groups (P = .125), as was waitlist time (P = .610). The need for mechanical ventilation (54.6% vs 35.8%; P = .005) and ECMO (17.9% vs 9.0%; P = .069) at 72 hours post-transplantation was greater in the DLRTx group. However, median post-transplantation hospital stay (21.5 [interquartile range (IQR), 12-35] days versus 20 [IQR, 12-35] days; P = .119) and in-hospital mortality (10.9% [n = 76/698] vs 12.4% [n = 24/193]; P = .547) were comparable in the 2 groups. Long-term survival was significantly better in the DLRTx group (P < .001, log-rank test). In the propensity score-weighted multivariable model, the DLRTx group had 28% lower risk of mortality at any point during follow-up compared to the SLRTx group (hazard ratio, 0.72; 95% confidence interval, 0.57-0.91; P = .006). Conclusions: The less invasiveness of single-lung transplantation in the retransplantation setting has minimal short-term benefit and is associated with significantly worse long-term survival. Double-lung retransplantation should remain the standard for lung retransplantation after initial double-lung transplantation.

Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis

Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis

Lung transplantation in idiopathic pulmonary fibrosis

SINGLE AND BILATERAL LUNG TRANSPLANTATION - ASSESSMENT OF PATIENTS AND FIRST RESULTS

Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study

Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome

Indications for and Outcomes after Combined Lung and Liver Transplantation: A Single-Center Experience on 13 Consecutive Cases

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible

Effect of Idiopathic Pulmonary Fibrosis Combined with Different Degrees of Pulmonary Hypertension on the Early Prognosis of Lung Transplantation

Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension

Risk Factors Related to Early Survival after Lung Transplantation for Idiopathic Pulmonary Fibrosis

Spirometric assessment of lung transplanted patients: one year follow-up

Outcomes of single vs double lung retransplantation in patients with cystic fibrosis

[Isolated Lung Transplantation--evaluation of Patients and Initial Results].

[Single-lung transplantation for end-stage pulmonary parenchymal diseases with pulmonary hypertension]

Double- and Single-Lung Transplantation: an Analysis of Twenty Years of OPTN/UNOS Registry Data.

Lung Transplantation in Patients with Previous or Unknown Oncological Disease: Evaluation of Short- and Long-Term Outcomes

Outcomes of single-lung retransplantation after double-lung transplantation

Extended Recipient Criteria in Lung Transplantation: Impact of Pleural Abnormalities on Primary Graft Dysfunction

Outcomes and Long-term Survival After Pulmonary Retransplantation: A Single-Center Experience

Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes